CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

Saved in:
Bibliographic Details
Title: CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Authors: Reiss KA; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Angelos MG; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Dees EC; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Yuan Y; City of Hope Cancer Center, Duarte, CA, USA.; Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Ueno NT; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; University of Hawai'i Cancer Center, Honolulu, HI, USA., Pohlmann PR; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson ML; Sarah Cancer Research Institute, Nashville, TN, USA., Chao J; City of Hope Cancer Center, Duarte, CA, USA., Shestova O; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Serody JS; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Schmierer M; Carisma Therapeutics, Philadelphia, PA, USA., Kremp M; Carisma Therapeutics, Philadelphia, PA, USA., Ball M; Carisma Therapeutics, Philadelphia, PA, USA., Qureshi R; Carisma Therapeutics, Philadelphia, PA, USA., Schott BH; Carisma Therapeutics, Philadelphia, PA, USA., Sonawane P; Carisma Therapeutics, Philadelphia, PA, USA., DeLong SC; Carisma Therapeutics, Philadelphia, PA, USA., Christiano M; Carisma Therapeutics, Philadelphia, PA, USA., Swaby RF; Carisma Therapeutics, Philadelphia, PA, USA., Abramson S; Carisma Therapeutics, Philadelphia, PA, USA., Locke K; Carisma Therapeutics, Philadelphia, PA, USA., Barton D; Carisma Therapeutics, Philadelphia, PA, USA., Kennedy E; Carisma Therapeutics, Philadelphia, PA, USA., Gill S; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Cushing D; Carisma Therapeutics, Philadelphia, PA, USA., Klichinsky M; Carisma Therapeutics, Philadelphia, PA, USA., Condamine T; Carisma Therapeutics, Philadelphia, PA, USA. Thomas.Condamine@carismatx.com., Abdou Y; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1171-1182. Date of Electronic Publication: 2025 Feb 07.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-025-03495-z